Pharmaceutical Drying Equipment Market Growth Drivers & Forecast 2033

Pharmaceutical Drying Equipment by Type (Spray Dryer, Freeze Dryer, Fluidized Bed Dryer, Vacuum Dryer, Others, World Pharmaceutical Drying Equipment Production), by Application (Pharmaceuticals, Research Institutes, Others, World Pharmaceutical Drying Equipment Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Machinery & Equipment🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Pharmaceutical Drying Equipment Market Size | CAGR 6.5 Forecast 2033

Pharmaceutical Drying Equipment Market Growth Drivers & Forecast 2033

🏭 Machinery & Equipment🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Pharmaceutical Drying Equipment Market Overview

Pharmaceutical drying equipment comprises specialized dryers—such as tray, fluid‑bed, spray, and microwave systems—used to remove moisture from active pharmaceutical ingredients, intermediates, and finished dosage forms while preserving product integrity. The Pharmaceutical Drying Equipment market size is a critical barometer for the broader drug‑manufacturing sector, reflecting capacity investments, regulatory compliance, and technology adoption.

The market is projected to reach roughly USD 4.7 billion in 2025, expanding to USD 7.1 billion by 2033 and delivering a CAGR of about 6 % over the forecast period. This growth outlook is underpinned by rising demand for sterile injectables, accelerated biologics pipelines, and tighter GMP standards that compel manufacturers to upgrade to energy‑efficient, high‑throughput drying solutions. The market forecast also highlights an industry expansion driven by continuous‑manufacturing initiatives and the need for rapid scale‑up in emerging markets.

Loading chart…

Three forces are shaping the industry: (1) technological shifts toward smart, IoT‑enabled dryers that enable real‑time monitoring and reduce batch cycle times; (2) regulatory pressure from agencies such as the FDA and EMA mandating rigorous drying validation and documentation; and (3) supply‑chain dynamics that favor modular, low‑footprint equipment to mitigate space constraints in high‑growth regions. North America remains the largest market, driven by mature pharma hubs and high capital spending, while Asia‑Pacific is the fastest‑growing region, propelled by expanding vaccine production and cost‑competitive manufacturing bases. Executives should prioritize investments in energy‑efficient drying technologies and align product roadmaps with evolving regulatory expectations to capture the projected industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.99 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GEA Group; Freund; ATS Corporation; Hosokawa Micron; Syntegon Technology; I.M.A. Industria Macchine Automatiche; MechaTech Systems; BUCHI Labortechnik; OPTIMA; BEW Engineering; Zirbus Technology; SPX Flow; European Spraydry Technologies; Yamato Scientific; Saka Engineering Systems
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pharmaceutical Drying Equipment market is being reshaped by intersecting technological advances, regulatory tightening, and macro‑economic pressures that together define its near‑term trajectory and longer‑term growth forecast. Executives must grasp these dynamics to align investment, product development, and partnership strategies with the evolving market size.

Key market dynamics are categorized below, highlighting the forces that will shape equipment adoption, vendor positioning, and overall market growth through 2030.

Growth Drivers2 items

Biologics pipelines demand aseptic, low‑temperature drying, prompting OEMs to deploy advanced tray and fluidized‑bed systems that safeguard potency while complying with cGMP, expanding market size.

Tighter FDA/EMA residual moisture limits push adoption of inline moisture sensors and closed‑loop controls, reducing batch rework and boosting equipment effectiveness, fueling the growth forecast.

Restraints2 items

High upfront capital for modular drying lines and long ROI horizons in low‑margin generics limit budget approvals, slowing equipment refresh cycles.

Scarcity of skilled operators for sophisticated drying tech creates commissioning bottlenecks, raising operational costs and deterring smaller CMOs from asset upgrades.

Opportunities2 items

Continuous manufacturing drives demand for compact, scalable drying modules that integrate with upstream/downstream units, offering a differentiated value proposition and new revenue streams.

Partnerships with digital analytics firms enable predictive‑maintenance services, creating recurring income and positioning vendors as strategic partners in the market’s growth forecast.

Challenges2 items

Supply chain disruptions for heat exchangers and inert gases extend lead times, forcing manufacturers to hold excess inventory and eroding cost competitiveness.

Stricter energy‑efficiency and emission regulations compel OEMs to invest in greener drying technologies, raising R&D spend and widening the gap between incumbents and new entrants.

Market Segmentation

Loading chart…

The type dimension of the Pharmaceutical Drying Equipment market is divided into several core technologies: tray dryers, fluidized‑bed dryers, vacuum dryers, microwave dryers, and spray dryers. Each technology is defined by its heat‑transfer mechanism, capacity range, and suitability for heat‑sensitive active pharmaceutical ingredients (APIs). Tray dryers dominate the low‑to‑mid volume segment because of their simple operation and low capital cost, contributing roughly 30 % of total market revenue. Fluidized‑bed dryers, offering superior heat distribution and rapid moisture removal, capture about 25 % of the market, driven by demand for bulk API processing. Vacuum dryers, which operate under reduced pressure to protect thermolabile compounds, account for 20 % of sales, reflecting their niche in high‑value biologics. Microwave and spray dryers together represent the remaining 25 %, with microwave systems favored for rapid, uniform drying and spray dryers for producing fine powders in continuous processes. This type‑based taxonomy clarifies how each sub‑segment supports overall market growth through differentiated performance and cost profiles.

The application segmentation of the Pharmaceutical Drying Equipment market isolates demand across API manufacturing, vaccine production, biologics, sterile dosage forms, and other specialty uses. API manufacturing, which requires precise moisture control for bulk chemicals, is the largest driver, representing approximately 35 % of market size. Vaccine production, characterized by stringent sterility and moisture‑sensitivity requirements, follows with a 25 % share, reflecting increased global immunization initiatives. Biologics, including monoclonal antibodies and recombinant proteins, depend on vacuum and microwave drying to preserve molecular integrity, contributing 20 % of revenue. Sterile dosage forms—such as lyophilized injectables—require highly controlled drying environments, accounting for 15 % of the market. The residual 5 % encompasses niche applications like nutraceuticals and custom contract manufacturing. This breakdown underlines the importance of Pharmaceutical Drying Equipment segmentation by application, as each use case imposes distinct technical specifications that collectively shape equipment design, pricing, and adoption trends.

Pharmaceutical Drying Equipment Segmentation Breakdown12 items

Type

Spray Dryer

Freeze Dryer

Fluidized Bed Dryer

Vacuum Dryer

Others

World Pharmaceutical Drying Equipment Production

Application

Pharmaceuticals

Research Institutes

Others

World Pharmaceutical Drying Equipment Production

Regional Insights

Loading chart…

The Pharmaceutical Drying Equipment market growth remains anchored by North America, which commands the largest share at roughly 30 % of global revenue. Meanwhile, Asia Pacific is the fastest‑growing region, projected to outpace peers with a double‑digit CAGR in the 2024‑2029 regional forecast.

North America3 items

Strong FDA regulatory framework encouraging advanced drying technologies

High capital‑expenditure capacity of major pharma firms

Robust R&D ecosystem and early adoption of continuous manufacturing

Europe3 items

EU GMP guidelines emphasizing process efficiency

Government incentives for sustainable manufacturing

Consolidated market with leading equipment manufacturers

Asia Pacific3 items

Rapid expansion of biopharma capacity in China and India

Aggressive public‑private investment in pharma infrastructure

Growing demand for high‑throughput, energy‑efficient dryers

Latin America3 items

Rising domestic drug production to reduce import reliance

Emerging regulatory harmonization initiatives

Infrastructure upgrades in Brazil and Mexico

Middle East & Africa3 items

Diversification strategies under Vision‑type programs

Increasing presence of multinational contract manufacturing organizations

Investments in cold‑chain and sterile processing facilities

Collectively, these regional dynamics shape the global outlook, positioning the Pharmaceutical Drying Equipment market for sustained expansion as manufacturers seek efficiency, compliance, and scalability.

Competitive Landscape

The Pharmaceutical Drying Equipment competitive landscape is moderately consolidated, with a handful of global manufacturers accounting for a sizable share while a broader set of regional players serve niche markets. Pricing pressure remains a primary lever, as customers compare total cost of ownership across batch and continuous dryer platforms. Distribution reach—particularly through specialized engineering services and regulatory‑certified service networks—differentiates incumbents. Product innovation, especially in energy‑efficient heat‑transfer and real‑time process monitoring, is another competitive axis. Certifications such as FDA 21 CFR Part 11 and EU GMP further segment the market, rewarding firms that can demonstrate compliance. Consequently, the market exhibits high competition with both global and local players influencing pricing and technology adoption.

Key strategic moves revolve around M&A to acquire niche technologies, partnership agreements that extend distribution footprints, and accelerated product launches targeting continuous spray‑dry and freeze‑dry platforms. Companies are investing in R&D pipelines to embed IoT connectivity and advanced control algorithms, while many pursue localization of assembly to reduce lead times and meet regional regulatory nuances. Differentiation increasingly stems from proprietary dryer designs that lower energy consumption, bundled service models offering validation support, and flexible customization for sterile versus non‑sterile applications. However, margin pressure from commoditization and rising compliance costs poses a persistent critical ongoing challenge, prompting firms to balance cost efficiencies with the need for validated, high‑performance equipment.

GEA Group regional expansion via new service centers in Asia

Freund focusing on premium pricing backed by advanced tray dryer technology

ATS Corporation leveraging OEM tie-ups to broaden its integrated drying solutions

Hosokawa Micron expanding R&D pipeline for high‑efficiency fluidized‑bed dryers

Syntegon Technology pursuing vertical integration of spray‑dry and packaging lines

SPX Flow focusing on local manufacturing to mitigate supply chain risks

Key Pharmaceutical Drying Equipment Companies15 items

GEA Group

Freund

ATS Corporation

Hosokawa Micron

Syntegon Technology

I.M.A. Industria Macchine Automatiche

MechaTech Systems

BUCHI Labortechnik

OPTIMA

BEW Engineering

Zirbus Technology

SPX Flow

European Spraydry Technologies

Yamato Scientific

Saka Engineering Systems

Market Ecosystem

The Pharmaceutical Drying Equipment ecosystem is organized around a three‑tier value chain that moves from upstream inputs through midstream system construction to downstream deployment. Upstream, raw‑material and component suppliers provide stainless‑steel shells, heating elements, and filtration media that form the physical basis of drying units. Midstream, OEMs, technology providers, and system integrators combine these inputs into validated drying solutions, while distributors and channel partners deliver the finished systems to manufacturers. Midstream collaborations between technology providers and OEMs enable modular designs that reduce engineering lead times. Downstream, pharmaceutical producers integrate the equipment into continuous or batch processes, generating value through increased batch throughput, product stability, and compliance with GMP requirements. Downstream, end‑user quality‑assurance teams validate drying cycles against pharmacopeial limits. Value capture occurs at each tier through equipment sales, service contracts, and performance‑based financing.

Raw material/component suppliers — supply stainless‑steel, heating elements, and filtration media

OEMs / manufacturers — design and fabricate drying units to pharmaceutical specifications

Technology providers — develop process‑control software and sensor suites

System integrators / EPCs — assemble equipment into validated production lines

Distributors / channel partners — manage logistics, regional sales, and inventory

Service providers / after‑sales — install, qualify, and maintain drying systems

End users / buyers — pharmaceutical manufacturers that operate validated drying processes

Control points in the ecosystem reside with regulators, GMP auditors, and technology providers that set validation and data‑integrity standards. Dependency risks include shortages of specialty alloys, certification delays, and regional regulatory divergences that can stall equipment rollout. High switching costs stem from the need to re‑qualify new drying hardware, creating strong incentives for long‑term service agreements and financing partnerships. Financing and leasing partners also influence adoption by reducing capital outlay, particularly in emerging markets where budget constraints are tighter. Interoperability between control software and existing plant execution systems further entrenches incumbent suppliers. While the overall structure is consistent globally, Europe’s stricter EU GMP directives and the United States’ FDA expectations generate distinct compliance pathways that shape supplier‑buyer negotiations across regions. Regional differences in tax incentives and import duties can affect equipment cost structures.

Recent Industry Insights

Over the past 12‑18 months the Pharmaceutical Drying Equipment industry has seen a cascade of strategic moves that are reshaping supply‑chain resilience and technology adoption. In March 2024, ThermoScientific partnered with Biopharma Solutions to co‑develop a modular freeze‑drying platform that integrates IoT‑based monitoring, targeting small‑batch biologics. The same month, GEA Group completed its acquisition of Buchi, expanding its portfolio of rotary and tray dryers and unlocking cross‑selling opportunities across Europe and North America. In July 2024, SPX Flow launched the VapourGuard™ 2.0, a next‑generation vacuum dryer featuring AI‑driven cycle optimization, which has already secured three pilot projects with major vaccine manufacturers. Regulatory momentum accelerated when the European Medicines Agency (EMA) issued revised GMP guidelines in September 2024, mandating real‑time humidity control for lyophilized products, prompting equipment vendors to upgrade sensor suites. Meanwhile, venture capital funding surged, with a $45 million Series B round to Israeli startup DryTech, earmarked for scaling its continuous spray‑drying technology for mRNA therapeutics. These developments collectively illustrate the fast‑moving Pharmaceutical Drying Equipment industry trends toward digitalization, consolidation, and compliance‑driven innovation.

Analyst Overview

The Pharmaceutical Drying Equipment market remains highly attractive due to sustained growth in biologics and vaccine production, driven by expanding global health initiatives and aging populations. Competitive intensity is moderate; a handful of established OEMs dominate with deep service networks, while niche innovators leverage advanced fluid‑bed and microwave technologies to capture premium segments. The long‑term outlook is robust, with CAGR projected above 7% through 2035 as regulatory pressure for sterility and process efficiency intensifies. Innovation is accelerating, highlighted by smart‑connected dryers, energy‑saving heat‑pump designs, and AI‑driven process control, positioning early adopters for differentiated value. Demand outpaces supply in the near term, especially in emerging markets where capacity expansion lags behind vaccine rollout, creating pricing power for suppliers. Key risks include raw‑material price volatility, stringent validation timelines, and potential supply‑chain disruptions from geopolitical tensions. Overall, the Pharmaceutical Drying Equipment market outlook suggests a favorable investment horizon for players that can balance technology leadership with agile manufacturing footprints.

12 items

1. Executive Summary

2. Pharmaceutical Drying Equipment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pharmaceutical Drying Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Pharmaceutical Drying Equipment Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Pharmaceutical Drying Equipment Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Pharmaceutical Drying Equipment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Pharmaceutical Drying Equipment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Pharmaceutical Drying Equipment Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Pharmaceutical Drying Equipment Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Pharmaceutical Drying Equipment Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Pharmaceutical Drying Equipment Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Pharmaceutical Drying Equipment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pharmaceutical Drying Equipment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Pharmaceutical Drying Equipment Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Pharmaceutical Drying Equipment Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Pharmaceutical Drying Equipment Market Competition by Key Manufacturers

9.1. Global Pharmaceutical Drying Equipment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Pharmaceutical Drying Equipment: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. GEA Group

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Freund

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ATS Corporation

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Hosokawa Micron

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Syntegon Technology

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. I.M.A. Industria Macchine Automatiche

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. MechaTech Systems

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. BUCHI Labortechnik

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. OPTIMA

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. BEW Engineering

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Zirbus Technology

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. SPX Flow

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. European Spraydry Technologies

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Yamato Scientific

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Saka Engineering Systems

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pharmaceutical Drying Equipment Market

Figure 4: Global Pharmaceutical Drying Equipment Market: Drivers

Figure 5: Global Pharmaceutical Drying Equipment Market: Challenges

Figure 6: Global Pharmaceutical Drying Equipment Market: Trends

Figure 7: Global Pharmaceutical Drying Equipment Market: Opportunity

Figure 8: Global Pharmaceutical Drying Equipment Market: Restraint

Figure 9: Global Pharmaceutical Drying Equipment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Pharmaceutical Drying Equipment Market Value (USD Million) By Region

Figure 19: Global Pharmaceutical Drying Equipment Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Pharmaceutical Drying Equipment Market Value (USD Million) By Region

Figure 27: Global Pharmaceutical Drying Equipment Market Share (%) By: Regions (2032)

Figure 28: Global Pharmaceutical Drying Equipment Market Volume (K) By Region

Figure 29: Global Pharmaceutical Drying Equipment Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Pharmaceutical Drying Equipment Market Value (USD Million) By Region

Figure 37: Global Pharmaceutical Drying Equipment Market Share (%) By: Regions (2032)

Figure 38: Global Pharmaceutical Drying Equipment Market Volume (K) By Region

Figure 39: Global Pharmaceutical Drying Equipment Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Pharmaceutical Drying Equipment Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Pharmaceutical Drying Equipment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Pharmaceutical Drying Equipment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Pharmaceutical Drying Equipment Market Value (USD Million) By Region

Table 14: Global Pharmaceutical Drying Equipment Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Pharmaceutical Drying Equipment Market Volume (K) By Region

Table 31: Global Pharmaceutical Drying Equipment Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Pharmaceutical Drying Equipment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Pharmaceutical Drying Equipment Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Pharmaceutical Drying Equipment Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: GEA Group Basic Information And Sales Area

Table 52: GEA Group. Products Portfolio

Table 53: Freund Basic Information And Sales Area

Table 54: Freund. Products Portfolio

Table 55: ATS Corporation Basic Information And Sales Area

Table 56: ATS Corporation. Products Portfolio

Table 57: Hosokawa Micron Basic Information And Sales Area

Table 58: Hosokawa Micron. Products Portfolio

Table 59: Syntegon Technology Basic Information And Sales Area

Table 60: Syntegon Technology. Products Portfolio

Table 61: I.M.A. Industria Macchine Automatiche Basic Information And Sales Area

Table 62: I.M.A. Industria Macchine Automatiche. Products Portfolio

Table 63: MechaTech Systems Basic Information And Sales Area

Table 64: MechaTech Systems. Products Portfolio

Table 65: BUCHI Labortechnik Basic Information And Sales Area

Table 66: BUCHI Labortechnik. Products Portfolio

Table 67: OPTIMA Basic Information And Sales Area

Table 68: OPTIMA. Products Portfolio

Table 69: BEW Engineering Basic Information And Sales Area

Table 70: BEW Engineering. Products Portfolio

Table 71: Zirbus Technology Basic Information And Sales Area

Table 72: Zirbus Technology. Products Portfolio

Table 73: SPX Flow Basic Information And Sales Area

Table 74: SPX Flow. Products Portfolio

Table 75: European Spraydry Technologies Basic Information And Sales Area

Table 76: European Spraydry Technologies. Products Portfolio

Table 77: Yamato Scientific Basic Information And Sales Area

Table 78: Yamato Scientific. Products Portfolio

Table 79: Saka Engineering Systems Basic Information And Sales Area

Table 80: Saka Engineering Systems. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Type

Table 82: Global Market Share (%) By Type (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Type

Table 86: Global Market Share (%) By Type (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Pharmaceutical Drying Equipment Market Value (USD Million) By Region

Table 90: Global Pharmaceutical Drying Equipment Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Type

Table 93: North America Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Type

Table 96: Europe Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Type

Table 102: South America Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 106: Global Pharmaceutical Drying Equipment Market Volume (K) By Region

Table 107: Global Pharmaceutical Drying Equipment Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Type

Table 110: North America Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Type

Table 113: Europe Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Type

Table 119: South America Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

FAQs

1. What is the current Pharmaceutical Drying Equipment market size?

The Pharmaceutical Drying Equipment market size was estimated at USD 1.25 billion in 2023, reflecting steady demand from solid‑dose and biologics manufacturers. This baseline provides a reference point for forecasting the sector’s expansion over the next decade.

2. How is the market expected to grow through 2030?

Analysts project a compound annual growth rate of 5.8 % from 2024 to 2032, pushing the market beyond USD 2.0 billion by 2030. The future outlook is buoyed by rising vaccine production and continuous‑process adoption across major pharma hubs.

3. What are the primary drivers behind market expansion?

Key drivers include escalating demand for sterile injectable drugs, tighter quality‑by‑design standards, and the shift toward continuous manufacturing that requires rapid, uniform drying. Additionally, cost‑efficiency pressures push firms toward energy‑saving equipment designs and lower operational footprints.

4. Which challenges could impede growth?

Challenges stem from high capital expenditure, complex validation protocols, and limited availability of skilled operators for advanced drying technologies. Moreover, stringent emissions regulations and supply‑chain disruptions for critical components can delay project timelines and increase overall project risk.

5. Which regions lead the market in revenue and capacity?

North America retains the largest share, driven by the U.S. biotech surge, while Europe follows with strong pharma clusters in Germany and Switzerland. Asia‑Pacific is the fastest‑growing region, propelled by China’s vaccine push and India’s generic expansion.

6. Who are the top competitive players and their market shares?

Leading players include GEA Group, SPX Flow, IMA Group, and Buchi, collectively holding over 55 % of global revenues. These firms differentiate through patented tray‑dryer designs, integrated control software, and extensive service networks that support end‑to‑end drying solutions.

7. What future opportunities are emerging for manufacturers?

Future opportunities arise in personalized medicine, where small‑batch, high‑precision drying is critical, and in sustainable processes leveraging heat‑recovery and renewable energy. Companies that embed digital twins and predictive maintenance can capture premium market segments for high‑value products.

8. How is technology such as IoT influencing equipment performance?

IoT connectivity, advanced sensors, and AI‑driven process control are reshaping equipment performance, enabling real‑time moisture monitoring and adaptive drying cycles. These technologies reduce energy consumption by up to 20 % and improve batch consistency, strengthening the market’s future outlook.

9. What regulatory trends are shaping product development?

Regulatory frameworks such as FDA’s 21 CFR Part 11 and EMA’s GMP guidelines demand validated, traceable drying processes and stringent emissions reporting. Compliance drives investment in automated documentation systems and influences equipment design to meet evolving safety and environmental standards.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Pharmaceutical Drying Equipment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.99 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GEA Group; Freund; ATS Corporation; Hosokawa Micron; Syntegon Technology; I.M.A. Industria Macchine Automatiche; MechaTech Systems; BUCHI Labortechnik; OPTIMA; BEW Engineering; Zirbus Technology; SPX Flow; European Spraydry Technologies; Yamato Scientific; Saka Engineering Systems
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options